- Sphingolipidosis (5C56.0)
- Lipoid dermatoarthritis (FA38.Y)
- Multicentric reticulohistiocytosis (EE8Y)
- Lipoid proteinosis (LD27.Y)
Definition of Hyperlipoproteinaemia: Disorders of lipoprotein metabolism that result in high levels of lipoproteins in the circulating blood
5C80.00 Primary hypercholesterolaemia
Definition of Primary hypercholesterolaemia: This is a genetic disorder characterised by high cholesterol levels, specifically very high levels of low-density lipoprotein (LDL, “bad cholesterol”), in the blood and early cardiovascular disease.
- Sitosterolaemia (5C52.1Y)
5C80.01 Secondary hypercholesterolaemia
- Code also the causing condition
5C80.0Z Hypercholesterolaemia unspecified
Definition of Hypertriglyceridaemia: A form of hyperlipidaemia characterised by abnormally elevated levels of triglyceride-rich lipoproteins in the blood. It is associated with an elevated risk of cardiovascular morbidity.
- Hyperlipidaemia, group B
- Endogenous hyperglyceridaemia
5C80.2 Mixed hyperlipidaemia
Definition of Mixed hyperlipidaemia: Elevated levels of both LDL cholesterol and triglycerides in the blood
- Hyperbetalipoproteinaemia with prebetalipoproteinaemia
- Hypercholesterolaemia with endogenous hyperglyceridaemia
- Hyperlipidaemia, group C
- cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein] (5C52.11)
Definition of Hyperalphalipoproteinaemia: A condition in which high-density lipoprotein is elevated in the blood.
5C80.Y Other specified hyperlipoproteinaemia
5C80.Z Hyperlipoproteinaemia unspecified
Definition of Hypolipoproteinaemia: Disorders characterised by low level of lipoproteins of any type in the blood
ICD 11 Code For Hypolipoproteinaemia
- High-density lipoprotein deficiency
Definition of Hypoalphalipoproteinaemia: A disorder characterised by low levels of high-density lipoprotein in the blood.
Definition of Hypobetalipoproteinaemia: Hypobetalipoproteinemia (HBL) constitutes a group of lipoprotein metabolism disorders that are characterised by permanently low levels (below the 5th percentile) of apolipoprotein B and LDL cholesterol. There are two types of HBL: familial hypobetalipoproteinemia and chylomicron retention disease (CMRD; see these terms). The familial form can be severe with early onset (abetalipoproteinemia/homozygous familial hypobetalipoproteinemia; see this term) or benign (benign familial hypobetalipoproteinemia; see this term). (Please add the sentence). Severe familial HBL and CMRD appear in infancy or childhood. As a result they are often associated with growth delay, diarrhoea with steatorrhoea, and fat malabsorption. Benign familial hypobetalipoproteinemia is generally asymptomatic, but in adults is occasionally associated with dietary intolerance to fat. HBL disorders are caused by mutations in proteins involved in the synthesis, secretion and catabolism of lipoproteins containing apolipoprotein B (LDL, VLDL and chylomicrons).
5C81.Y Other specified hypolipoproteinaemia
5C81.Z Hypolipoproteinaemia unspecified
Other specified disorders of lipoprotein metabolism or lipidaemias
ICD 11 Code For Other specified disorders of lipoprotein metabolism or lipidaemias
5C8Y Other specified disorders of lipoprotein metabolism or lipidaemias
Unspecified disorders of lipoprotein metabolism or lipidaemias
ICD 11 Code For Unspecified disorders of lipoprotein metabolism or lipidaemias
5C8Z Unspecified disorders of lipoprotein metabolism or lipidaemias
Metabolic or transporter liver disease
ICD 11 Code For Metabolic or transporter liver disease
5C90 Metabolic or transporter liver disease
- Alcoholic liver disease (DB94)
- Non-alcoholic fatty liver disease (DB92)
- Drug-induced or toxic liver disease (DB95)
- Acute fatty liver of pregnancy (JA65.0)
- Bile acid synthesis defect with cholestasis (5C52.11)
- Progressive familial intrahepatic cholestasis (5C58.03)
- Benign recurrent intrahepatic cholestasis (5C58.04)
- Glycogen storage disease (5C51.3)
- Disorders of galactose metabolism (5C51.4)
- Disorders of fructose metabolism (5C51.5)
- Alpha-1-antitrypsin deficiency (5C5A)
- Reye syndrome (8E46)
5C90.0 Liver diseases due to urea cycle defects
Definition of Liver diseases due to urea cycle defects: This is a group of liver diseases due to defects in the urea cycle, which is a metabolic cycle of nitrogen-containing compounds that produces the waste product urea.
- Argininosuccinic aciduria (5C50.A0)
- Carbamoylphosphate synthetase deficiency (5C50.A1)
- Argininaemia (5C50.A2)
- Ornithine carbamoyltransferase deficiency (5C50.AY)
5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport
Definition of Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport: These are liver diseases due to disorders of porphyrin and bilirubin metabolism and transport
- Defects of catalase and peroxidase (5C58)
- Porphyria cutanea tarda (5C58.10)
- Variegate porphyria (5C58.13)
- Crigler-Najjar syndrome (5C58.00)
- Gilbert syndrome (5C58.01)
- Dubin-Johnson syndrome (5C58.02)
- Rotor syndrome (5C58.0Y)
5C90.2 Liver diseases due to disorders of amino acid metabolism
Definition of Liver diseases due to disorders of amino acid metabolism: This is liver disease due to the disorder of the various biochemical processes responsible for the synthesis of proteins and amino acids, and the breakdown of proteins (and other large molecules, too) by catabolism.
5C90.3 Liver disease due to disorders of lysosomal storage
Definition of Liver disease due to disorders of lysosomal storage: This is liver disease due to a group of approximately 50 rare inherited metabolic disorders that result from defects in lysosomal function.
- Gaucher disease (5C56.0Y)
- Niemann-Pick disease (5C56.0Y)
- Wolman disease (5C56.0Y)
- Cholesteryl ester storage disease (5C56.0Y)
5C90.4 Liver diseases due to mitochondrial disorders
Definition of Liver diseases due to mitochondrial disorders: This is liver disease due to a group of disorders caused by dysfunctional mitochondria, the organelles that generate energy for the cell.
5C90.5 Liver diseases due to disorders of mineral metabolism
Definition of Liver diseases due to disorders of mineral metabolism: This is a liver disease due to a disorder of the organic compound required by an organism as a vital nutrient in limited amounts.
- Code also the causing condition
5C90.Y Other specified metabolic or transporter liver disease
5C90.Z Metabolic or transporter liver disease unspecified